UMCCR moved its genomics analysis to Illumina Connected Analytics with DRAGEN to speed cancer reporting.
UMCCR's Genomics Platform Group needed a scalable cloud environment to replace a hybrid HPC setup for sequencing workflows. It adopted Illumina Connected Analytics on AWS, integrated with the DRAGEN Bio-IT Platform. The page states analysis turnaround of 6-7 hours and curated reports within 7 days, in a commercially supported production environment.
Illumina is the leading DNA sequencing company, also offering cloud genomic analysis software and AI variant-interpretation models such as PrimateAI and SpliceAI.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Illumina on its own site — read the original case study on illumina.com ↗
Related use cases
- 01Okayama University ran a five-month COPD multiomics project on Illumina Connected Analytics with DRAGEN pipelines.
- 02Illumina and AstraZeneca are combining PrimateAI and SpliceAI with AstraZeneca's AI tools to improve drug target discovery.
- 03Transforming Content Operations for 2x Faster Time to Market
- 04Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 05How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 06Reaching Underserved Communities with Smarter Targeting